Artiva Biotherapeutics, Inc. ARTV
3.83 USD +0.06 (+1.59%)
Regular-session close
3.83 0.00 0.00%
After hours · Nov 19, 4:01 PM ET
3.79 Day range 3.93
2.96 52-week range 14.53
- YTD
- -10.72%
- 1 year
- +12.98%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -89.81M | -67.28M | -30.67M | -59.83M | |
| -83.86M | -65.37M | -28.72M | -58.79M | |
| -3.43 | -5.81 | -35.78 | -77.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 27.16M | 40.49M | 53.76M | 102.78M | |
| 130.94M | 209.58M | 105.11M | 133.05M | |
| 20.97M | 22.94M | 50.72M | 57.34M | |
| 10.94M | 14.35M | 42.01M | 19.45M | |
| 109.97M | 186.64M | -162.01M | -140.70M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -76.75M | -55.03M | -47.43M | -50.83M | |
| 63.41M | -120.46M | -25.98M | -6.30M | |
| 9.00K | 162.23M | 24.39M | -1.26M | |
| -2.59M | -642.00K | -3.26M | -6.30M | |
| -13.33M | -13.27M | -49.01M | -58.39M |
